BioSpace News Archive

Business

Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022

Zealand Pharma A/S announced that it will host a conference call on May 12, 2022 at 4 pm CET following the announcement of results for the first quarter of 2022.

May 5, 2022
·
3 min read
Business

Egle Therapeutics Appoints Pierre Legault as Chairman and Board Member

Egle Therapeutics SAS, an emerging biotechnology company dedicated to developing novel immunotherapies for oncology and autoimmune diseases, is pleased to announce Pierre Legault as Chairman and board member as of March 2022.

May 5, 2022
·
2 min read
Biotech Beach

Progenity Announces Successful Transfer of Liquid Biopsy Technologies

Progenity, Inc. announced it has completed the divesture of a collection of novel, discovery-stage biochemical and bioinformatics technologies, including single-molecule detection, which are designed to enable next-generation rapid, low-cost assessment of biomolecules via liquid biopsy.

May 5, 2022
·
5 min read
Business

Zentalis Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update

Zentalis Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2022 and highlighted recent corporate accomplishments.

May 5, 2022
·
9 min read
Pharm Country

LAVA Therapeutics to Participate at the UBS Global Healthcare Conference

LAVA Therapeutics N.V. announced that Stephen Hurly, president and chief executive officer of LAVA Therapeutics, will participate in a fireside chat at the UBS Global Healthcare Conference 2022 being held in New York, NY.

May 5, 2022
·
1 min read
Business

Orchard Therapeutics to Webcast Conference Call of First Quarter 2022 Financial Results

Orchard Therapeutics announced that the company will host a conference call and live webcast on Thursday, May 12, 2022, at 8:00 a.m. ET to review business updates and its first quarter 2022 financial results.

May 5, 2022
·
2 min read
BioMidwest

Clearside Biomedical Poster Presentation at ARVO 2022 Annual Meeting Demonstrates Versatility of Suprachoroidal Delivery Technology

Clearside Biomedical, Inc. announced that several poster presentations were delivered on Clearside’s proprietary suprachoroidal delivery platform, XIPERE®, and gene therapy delivery utilizing Clearside’s SCS Microinjector® at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting.

May 5, 2022
·
9 min read
Business

AVEO Oncology Reports First Quarter 2022 Financial Results

AVEO Oncology today reported financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
19 min read
Lone Star Bio

Aravive to Host Key Opinion Leader Symposium on May 11, 2022

Aravive, Inc. today announced that it will host a Key Opinion Leader (KOL) Symposium on the GAS6-AXL signaling pathway and the Company’s lead drug candidate, batiraxcept.

May 5, 2022
·
2 min read
Drug Development

Algernon Pharmaceuticals Announces Last Patient Treated in Phase 2 Study of IPF and Chronic Cough

Algernon Pharmaceuticals Inc. is pleased to announce that the last patient has completed the treatment period in its Phase 2 proof of concept study of NP-120 (“Ifenprodil”) for idiopathic pulmonary fibrosis (“IPF”) and chronic cough.

May 5, 2022
·
4 min read